SUPERNUS PHARMACEUTICALS INC's ticker is SUPN and the CUSIP is 868459108. A total of 261 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q4 2022. The put-call ratio across all filers is 0.01 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $554,378 | -13.1% | 20,108 | -5.3% | 0.01% | 0.0% |
| Q2 2023 | $637,993 | -19.1% | 21,224 | -2.5% | 0.01% | -27.8% |
| Q1 2023 | $788,691 | -0.0% | 21,769 | -1.6% | 0.02% | -21.7% |
| Q4 2022 | $788,878 | +25.4% | 22,116 | +1.7% | 0.02% | +15.0% |
| Q2 2022 | $629,000 | -9.5% | 21,750 | +1.1% | 0.02% | +5.3% |
| Q1 2022 | $695,000 | +13.2% | 21,511 | +2.2% | 0.02% | +18.8% |
| Q4 2021 | $614,000 | +9.6% | 21,051 | 0.0% | 0.02% | 0.0% |
| Q3 2021 | $560,000 | – | 21,051 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ASHFORD CAPITAL MANAGEMENT INC | 921,962 | $33,402,683 | 5.00% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 423,500 | $15,326,465 | 4.28% |
| ARMISTICE CAPITAL, LLC | 4,350,000 | $157,600,500 | 2.27% |
| S&T BANK/PA | 223,775 | $8,107 | 1.46% |
| Aristotle Capital Boston, LLC | 1,155,149 | $41,851,071 | 1.29% |
| Tributary Capital Management, LLC | 353,671 | $12,813,500 | 1.19% |
| Bridge City Capital, LLC | 62,790 | $2,274,882 | 1.14% |
| RICE HALL JAMES & ASSOCIATES, LLC | 551,285 | $19,973,056 | 1.14% |
| Intrinsic Edge Capital Management LLC | 289,704 | $10,495,976 | 1.05% |
| Parkman Healthcare Partners LLC | 131,878 | $4,777,940 | 1.04% |